2nd Drug Study
-
Upload
maiko-dan-ty-manalo -
Category
Documents
-
view
215 -
download
0
Transcript of 2nd Drug Study
-
7/27/2019 2nd Drug Study
1/3
Name Indications Classifications Side Effects Contraindications Nursing
Considerations
Cefuroxime
750mg IV
It is effective for the
treatment of
penicillin ase-producing
Neisseria gonorrhoea
(PPNG). Effectively
treats bone and joint
infections, bronchitis,
meningitis,
gonorrhea, otitis
media,
pharyngitis/tonsillitis,
sinusitis, lower
respiratory tractinfections, skin and
soft tissue infections,
urinary tract
infections, and is
used for surgical
prophylaxis, reducing
or eliminating
infection.
ANTIINFECTIVE;
ANTIBIOTIC;
SECOND-GENERATION
CEPHALOSPORIN
Body as a Whole:
Thrombophlebitis (IV
site); pain, burning,cellulitis (IM site);
superinfections,
positive Coombs'
test.
GI:
Diarrhea,
nausea, antibiotic-
associated colitis.
Skin:Rash, pruritus,
urticaria.
Urogenital:
Increased serum
creatinine and BUN,
decreased creatinine
clearance.
Hypersensitivity to
cephalosporins and
related antibiotics;pregnancy
(category B),
lactation
>Determine history
of hypersensitivity
reactions tocephalosporins,
penicillins, and
history of allergies,
particularly to drugs,
before therapy is
initiated.
>Inspect IM and IV
injection sites
frequently for signs
of phlebitis.
>Report onset of
loose stools or
diarrhea. Although
pseudo membranous
colitis.
>Monitor I&O rates
and pattern:
Especially importantin severely ill patients
receiving high doses.
Report any significant
changes.
-
7/27/2019 2nd Drug Study
2/3
Name Indications Classifications Side Effects Contraindications Nursing
Considerations
Ketorelac
(Toradol)
IM 30mg/amp1 amp
Short term
management of pain
(not to exceed 5 daystotal for all routes
combined)
Ophthalmic: relief of
ocular itching due to
seasonal
conjunctivitis and
relief of post-
operative
inflammation after
cataract surgery.
Nonsteroidal
anti-inflammatory
agents, nonopioidanalagesics
CNS:
Drowsiness
abnormal thinkingdizziness
euphoria
headache-
- RESP:
asthma
dyspnea
- CV:
edema
pallor
vasodilation
- GI:GI Bleeding
abnormal taste
diarrhea
dry mouth
dyspepsia
GI pain
nausea
- GU:
oliguria
renal toxicityurinary frequency
Hypersensitivity
- Cross-sensitivity
with other NSAIDsmay existPre- or
perioperative use
- Known alcohol
intoleranceUse
cautiously in:
1) History of GI
bleeding
2) Renal impair-ment
(dosage reduction
may be required)
3) Cardiovasculardisease
- Patients who have
asthma, aspirin-
induced allergy, andnasal polyps are at
increased risk for
developing
hypersensitivity
reactions. Assess for
rhinitis, asthma, and
urticaria.
- Assess pain (note
type, location, and
intensity) prior to
and 1-2 hr followingadministration.
- Ketorolac therapy
should always be
given initially by the
IM or IV route. Oral
therapy should be
used only as a
continuation of
parenteral therapy.
- Caution patient toavoid concurrent use
of alcohol, aspirin,
NSAIDs,
acetaminophen, or
other OTC
medications without
consulting health
care professional.
-
7/27/2019 2nd Drug Study
3/3